...
首页> 外文期刊>Medicinal chemistry >Synthesis and Cytotoxic Evaluation of Quinazolin-4(3H)-one Derivatives Bearing Thiocarbamate, Thiourea or N-Methyldithiocarbamate Side Chains.
【24h】

Synthesis and Cytotoxic Evaluation of Quinazolin-4(3H)-one Derivatives Bearing Thiocarbamate, Thiourea or N-Methyldithiocarbamate Side Chains.

机译:带有硫代氨基甲酸酯,硫脲或N-甲基二硫代氨基甲酸酯侧链的喹唑啉-4(3H)-一衍生物的合成和细胞毒性评估。

获取原文
获取原文并翻译 | 示例
           

摘要

We have previously found that the dithiocarbamate derivatives of quinazolin-4(3H)-one could act as cytotoxic agents against a panel of human tumor cell lines. To investigate the contribution of dithiocarbamate moiety to the cytotoxic activity, three series of novel quinazolin-4(3H)-one derivatives bearing thiocarbamate, thiourea or Nmethyldithiocarbamate side chains were synthesized and tested for their cytotoxic activity against human cancer cell lines A549, MCF-7, HeLa, HT29 and HCT-116 by MTT assay. The results showed that transformation of the dithiocarbamate moiety in lead compound I to thiocarbamate or thiourea led to a decrease or loss of cytotoxic activity. Some N-alkylated analogs of lead compound II preferentially inhibited the proliferation of A549 cells, although their potencies were not improved in comparison with the unalkylated counterparts. The structure-activity relationship obtained in this research will be beneficial for further synthesis and discovery of effective cytotoxic agents.
机译:我们以前已经发现,quinazolin-4(3H)-one的二硫代氨基甲酸酯衍生物可以作为针对人类肿瘤细胞系的细胞毒剂。为了研究二硫代氨基甲酸酯部分对细胞毒性活性的贡献,合成了三系列带有硫代氨基甲酸酯,硫脲或Nmethyldithiocarbamate侧链的新型喹唑啉-4(3H)-一衍生物,并测试了其对人癌细胞系A549,MCF-的细胞毒活性。参照图7,通过MTT法测定HeLa,HT29和HCT-116。结果表明,铅化合物I中的二硫代氨基甲酸酯部分向硫代氨基甲酸酯或硫脲的转化导致细胞毒性活性的降低或丧失。铅化合物II的一些N-烷基化类似物优先抑制A549细胞的增殖,尽管与未烷基化的对应物相比,其效力没有提高。在这项研究中获得的结构活性关系将有助于进一步合成和发现有效的细胞毒剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号